{
    "id": 31282,
    "fullName": "AHCYL2 - BRAF",
    "impact": "fusion",
    "proteinEffect": "no effect - predicted",
    "geneVariantDescriptions": [
        {
            "description": "AHCYL2-BRAF results from the fusion of AHCYL2 and BRAF, which does not lead to Erk phosphorylation and is not transforming in cell culture (PMID: 28512244), and therefore, is predicted to have no effect on protein function. AHCYL2-BRAF has been identified in cutaneous melanoma (PMID: 28512244).",
            "references": [
                {
                    "id": 9257,
                    "pubMedId": 28512244,
                    "title": "Engineering and Functional Characterization of Fusion Genes Identifies Novel Oncogenic Drivers of Cancer.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/28512244"
                }
            ]
        }
    ],
    "type": null,
    "gene": {
        "id": 23382,
        "geneSymbol": "AHCYL2",
        "terms": [
            "AHCYL2",
            "ADOHCYASE3",
            "IRBIT2"
        ]
    },
    "variant": "AHCYL2 - BRAF",
    "createDate": "10/18/2019",
    "updateDate": "10/18/2019",
    "referenceTranscriptCoordinates": null,
    "partnerGenes": [
        {
            "gene": {
                "id": 673,
                "geneSymbol": "BRAF",
                "terms": [
                    "BRAF",
                    "B-raf",
                    "B-RAF1",
                    "BRAF1",
                    "NS7",
                    "RAFB1"
                ]
            }
        }
    ],
    "evidence": [
        
    ],
    "molecularProfiles": [
        {
            "id": 33625,
            "profileName": "AHCYL2 - BRAF",
            "profileTreatmentApproaches": [
                
            ]
        }
    ],
    "allTranscriptCoordinates": [
        
    ]
}